Working… Menu

A Study of TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01323244
Recruitment Status : Completed
First Posted : March 25, 2011
Last Update Posted : April 4, 2016
Information provided by (Responsible Party):
Janssen R&D Ireland